Back to Search
JILL MABLEY, MD
MD
Emergency Medicine Physician
NPI: 1952367138Individual
Specialties, Licenses & Credentials
Emergency Medicine PhysicianPrimary
Emergency Medicine
Code: 207P00000X
021581(GA)
Research & Publications (20)
Xanthine oxidase inhibitor allopurinol attenuates the development of diabetic cardiomyopathy.
PMID 19175688·J Cell Mol Med·2009
8-other
The novel inosine analogue INO-2002 exerts an anti-inflammatory effect in a murine model of acute lung injury.
PMID 19174745·Shock·2009
7-preclinical
PCB-induced endothelial cell dysfunction: role of poly(ADP-ribose) polymerase.
PMID 19549508·Biochem Pharmacol·2009
7-preclinical
The novel inosine analogue, INO-2002, protects against diabetes development in multiple low-dose streptozotocin and non-obese diabetic mouse models of type I diabetes.
PMID 18562629·J Endocrinol·2008
7-preclinical
Inhibition of poly(adenosine diphosphate-ribose) polymerase by the active form of vitamin D.
PMID 17487428·Int J Mol Med·2007
7-preclinical
Beneficial effects of a novel ultrapotent poly(ADP-ribose) polymerase inhibitor in murine models of heart failure.
PMID 16391839·Int J Mol Med·2006
7-preclinical
Gender differences in the endotoxin-induced inflammatory and vascular responses: potential role of poly(ADP-ribose) polymerase activation.
PMID 16079296·J Pharmacol Exp Ther·2005
7-preclinical
Role for nitrosative stress in diabetic neuropathy: evidence from studies with a peroxynitrite decomposition catalyst.
PMID 15611153·FASEB J·2005
7-preclinical
Potential role for 8-oxoguanine DNA glycosylase in regulating inflammation.
PMID 15677345·FASEB J·2005
7-preclinical
Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies.
PMID 15723618·Curr Med Chem·2005
6-review
Role of nitrosative stress and poly(ADP-ribose) polymerase activation in diabetic vascular dysfunction.
PMID 16026321·Curr Vasc Pharmacol·2005
6-review
Discovery of potent poly(ADP-ribose) polymerase-1 inhibitors from the modification of indeno[1,2-c]isoquinolinone.
PMID 16078828·J Med Chem·2005
8-other
A new, potent poly(ADP-ribose) polymerase inhibitor improves cardiac and vascular dysfunction associated with advanced aging.
PMID 15213249·J Pharmacol Exp Ther·2004
7-preclinical
Activation of poly(ADP-ribose) polymerase in circulating leukocytes during myocardial infarction.
PMID 14770035·Shock·2004
7-preclinical
Effects of poly(ADP-ribose) polymerase inhibition on inflammatory cell migration in a murine model of asthma.
PMID 14976461·Med Sci Monit·2004
7-preclinical
The combined inducible nitric oxide synthase inhibitor and free radical scavenger guanidinoethyldisulfide prevents multiple low-dose streptozotocin-induced diabetes in vivo and interleukin-1beta-induced suppression of islet insulin secretion in vitro.
PMID 15028959·Pancreas·2004
7-preclinical
Suppression of intestinal polyposis in Apcmin/+ mice by targeting the nitric oxide or poly(ADP-ribose) pathways.
PMID 15063141·Mutat Res·2004
7-preclinical
The therapeutic effects of PJ34 [N-(6-oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide.HCl], a selective inhibitor of poly(ADP-ribose) polymerase, in experimental allergic encephalomyelitis are associated with immunomodulation.
PMID 15159442·J Pharmacol Exp Ther·2004
7-preclinical
Left ventricular pressure-volume relationship in a rat model of advanced aging-associated heart failure.
PMID 15231502·Am J Physiol Heart Circ Physiol·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 660 W CROSSVILLE RD, SUITE 110
ROSWELL, GA 30075 - Phone
- (678) 555-5555
Quick Facts
- NPI
- 1952367138
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile